924 related articles for article (PubMed ID: 31409398)
1. RTS,S/AS01E immunization increases antibody responses to vaccine-unrelated Plasmodium falciparum antigens associated with protection against clinical malaria in African children: a case-control study.
Dobaño C; Ubillos I; Jairoce C; Gyan B; Vidal M; Jiménez A; Santano R; Dosoo D; Nhabomba AJ; Ayestaran A; Aguilar R; Williams NA; Díez-Padrisa N; Lanar D; Chauhan V; Chitnis C; Dutta S; Gaur D; Angov E; Asante KP; Owusu-Agyei S; Valim C; Gamain B; Coppel RL; Cavanagh D; Beeson JG; Campo JJ; Moncunill G
BMC Med; 2019 Aug; 17(1):157. PubMed ID: 31409398
[TBL] [Abstract][Full Text] [Related]
2. Baseline exposure, antibody subclass, and hepatitis B response differentially affect malaria protective immunity following RTS,S/AS01E vaccination in African children.
Ubillos I; Ayestaran A; Nhabomba AJ; Dosoo D; Vidal M; Jiménez A; Jairoce C; Sanz H; Aguilar R; Williams NA; Díez-Padrisa N; Mpina M; Sorgho H; Agnandji ST; Kariuki S; Mordmüller B; Daubenberger C; Asante KP; Owusu-Agyei S; Sacarlal J; Aide P; Aponte JJ; Dutta S; Gyan B; Campo JJ; Valim C; Moncunill G; Dobaño C
BMC Med; 2018 Oct; 16(1):197. PubMed ID: 30376866
[TBL] [Abstract][Full Text] [Related]
3. Differential Patterns of IgG Subclass Responses to
Dobaño C; Santano R; Vidal M; Jiménez A; Jairoce C; Ubillos I; Dosoo D; Aguilar R; Williams NA; Díez-Padrisa N; Ayestaran A; Valim C; Asante KP; Owusu-Agyei S; Lanar D; Chauhan V; Chitnis C; Dutta S; Angov E; Gamain B; Coppel RL; Beeson JG; Reiling L; Gaur D; Cavanagh D; Gyan B; Nhabomba AJ; Campo JJ; Moncunill G
Front Immunol; 2019; 10():439. PubMed ID: 30930896
[TBL] [Abstract][Full Text] [Related]
4. RTS,S/AS01
Suau R; Vidal M; Aguilar R; Ruiz-Olalla G; Vázquez-Santiago M; Jairoce C; Nhabomba AJ; Gyan B; Dosoo D; Asante KP; Owusu-Agyei S; Campo JJ; Izquierdo L; Cavanagh D; Coppel RL; Chauhan V; Angov E; Dutta S; Gaur D; Beeson JG; Moncunill G; Dobaño C
Vaccine; 2021 Jan; 39(4):687-698. PubMed ID: 33358704
[TBL] [Abstract][Full Text] [Related]
5. Impact of the RTS,S malaria vaccine candidate on naturally acquired antibody responses to multiple asexual blood stage antigens.
Campo JJ; Dobaño C; Sacarlal J; Guinovart C; Mayor A; Angov E; Dutta S; Chitnis C; Macete E; Aponte JJ; Alonso PL
PLoS One; 2011; 6(10):e25779. PubMed ID: 22022448
[TBL] [Abstract][Full Text] [Related]
6. Assessment of humoral immune responses to blood-stage malaria antigens following ChAd63-MVA immunization, controlled human malaria infection and natural exposure.
Biswas S; Choudhary P; Elias SC; Miura K; Milne KH; de Cassan SC; Collins KA; Halstead FD; Bliss CM; Ewer KJ; Osier FH; Hodgson SH; Duncan CJ; O'Hara GA; Long CA; Hill AV; Draper SJ
PLoS One; 2014; 9(9):e107903. PubMed ID: 25254500
[TBL] [Abstract][Full Text] [Related]
7. Concentration and avidity of antibodies to different circumsporozoite epitopes correlate with RTS,S/AS01E malaria vaccine efficacy.
Dobaño C; Sanz H; Sorgho H; Dosoo D; Mpina M; Ubillos I; Aguilar R; Ford T; Díez-Padrisa N; Williams NA; Ayestaran A; Traore O; Nhabomba AJ; Jairoce C; Waitumbi J; Agnandji ST; Kariuki S; Abdulla S; Aponte JJ; Mordmüller B; Asante KP; Owusu-Agyei S; Tinto H; Campo JJ; Moncunill G; Gyan B; Valim C; Daubenberger C
Nat Commun; 2019 May; 10(1):2174. PubMed ID: 31092823
[TBL] [Abstract][Full Text] [Related]
8. Antibody levels to multiple malaria vaccine candidate antigens in relation to clinical malaria episodes in children in the Kasena-Nankana district of Northern Ghana.
Dodoo D; Atuguba F; Bosomprah S; Ansah NA; Ansah P; Lamptey H; Egyir B; Oduro AR; Gyan B; Hodgson A; Koram KA
Malar J; 2011 May; 10():108. PubMed ID: 21529376
[TBL] [Abstract][Full Text] [Related]
9. Immunoglobulin G subclass and antibody avidity responses in Malian children immunized with Plasmodium falciparum apical membrane antigen 1 vaccine candidate FMP2.1/AS02
Berry AA; Gottlieb ER; Kouriba B; Diarra I; Thera MA; Dutta S; Coulibaly D; Ouattara A; Niangaly A; Kone AK; Traore K; Tolo Y; Mishcherkin V; Soisson L; Diggs CL; Blackwelder WC; Laurens MB; Sztein MB; Doumbo OK; Plowe CV; Lyke KE
Malar J; 2019 Jan; 18(1):13. PubMed ID: 30658710
[TBL] [Abstract][Full Text] [Related]
10. RTS,S vaccination is associated with serologic evidence of decreased exposure to Plasmodium falciparum liver- and blood-stage parasites.
Campo JJ; Aponte JJ; Skinner J; Nakajima R; Molina DM; Liang L; Sacarlal J; Alonso PL; Crompton PD; Felgner PL; Dobaño C
Mol Cell Proteomics; 2015 Mar; 14(3):519-31. PubMed ID: 25547414
[TBL] [Abstract][Full Text] [Related]
11. Effect of the pre-erythrocytic candidate malaria vaccine RTS,S/AS01E on blood stage immunity in young children.
Bejon P; Cook J; Bergmann-Leitner E; Olotu A; Lusingu J; Mwacharo J; Vekemans J; Njuguna P; Leach A; Lievens M; Dutta S; von Seidlein L; Savarese B; Villafana T; Lemnge MM; Cohen J; Marsh K; Corran PH; Angov E; Riley EM; Drakeley CJ
J Infect Dis; 2011 Jul; 204(1):9-18. PubMed ID: 21628653
[TBL] [Abstract][Full Text] [Related]
12. Safety and Immunogenicity of Seven Dosing Regimens of the Candidate RTS,S/AS01E Malaria Vaccine Integrated Within an Expanded Program on Immunization Regimen: A Phase II, Single-Center, Open, Controlled Trial in Infants in Malawi.
Witte D; Cunliffe NA; Turner AM; Ngulube E; Ofori-Anyinam O; Vekemans J; Chimpeni P; Lievens M; Wilson TP; Njiram'madzi J; Mendoza YG; Leach A
Pediatr Infect Dis J; 2018 May; 37(5):483-491. PubMed ID: 29432383
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of RTS,S/AS01E malaria vaccine and exploratory analysis on anti-circumsporozoite antibody titres and protection in children aged 5-17 months in Kenya and Tanzania: a randomised controlled trial.
Olotu A; Lusingu J; Leach A; Lievens M; Vekemans J; Msham S; Lang T; Gould J; Dubois MC; Jongert E; Vansadia P; Carter T; Njuguna P; Awuondo KO; Malabeja A; Abdul O; Gesase S; Mturi N; Drakeley CJ; Savarese B; Villafana T; Lapierre D; Ballou WR; Cohen J; Lemnge MM; Peshu N; Marsh K; Riley EM; von Seidlein L; Bejon P
Lancet Infect Dis; 2011 Feb; 11(2):102-9. PubMed ID: 21237715
[TBL] [Abstract][Full Text] [Related]
14. Distinct Helper T Cell Type 1 and 2 Responses Associated With Malaria Protection and Risk in RTS,S/AS01E Vaccinees.
Moncunill G; Mpina M; Nhabomba AJ; Aguilar R; Ayestaran A; Sanz H; Campo JJ; Jairoce C; Barrios D; Dong Y; Díez-Padrisa N; Fernandes JF; Abdulla S; Sacarlal J; Williams NA; Harezlak J; Mordmüller B; Agnandji ST; Aponte JJ; Daubenberger C; Valim C; Dobaño C
Clin Infect Dis; 2017 Sep; 65(5):746-755. PubMed ID: 28505356
[TBL] [Abstract][Full Text] [Related]
15. Strong off-target antibody reactivity to malarial antigens induced by RTS,S/AS01E vaccination is associated with protection.
Macià D; Campo JJ; Moncunill G; Jairoce C; Nhabomba AJ; Mpina M; Sorgho H; Dosoo D; Traore O; Kusi KA; Williams NA; Oberai A; Randall A; Sanz H; Valim C; Asante KP; Owusu-Agyei S; Tinto H; Agnandji ST; Kariuki S; Gyan B; Daubenberger C; Mordmüller B; Petrone P; Dobaño C
JCI Insight; 2022 May; 7(10):. PubMed ID: 35446785
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of RTS,S/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: a randomised trial.
Bojang KA; Milligan PJ; Pinder M; Vigneron L; Alloueche A; Kester KE; Ballou WR; Conway DJ; Reece WH; Gothard P; Yamuah L; Delchambre M; Voss G; Greenwood BM; Hill A; McAdam KP; Tornieporth N; Cohen JD; Doherty T;
Lancet; 2001 Dec; 358(9297):1927-34. PubMed ID: 11747915
[TBL] [Abstract][Full Text] [Related]
17. The effect of immunization schedule with the malaria vaccine candidate RTS,S/AS01E on protective efficacy and anti-circumsporozoite protein antibody avidity in African infants.
Ajua A; Lell B; Agnandji ST; Asante KP; Owusu-Agyei S; Mwangoka G; Mpina M; Salim N; Tanner M; Abdulla S; Vekemans J; Jongert E; Lievens M; Cambron P; Ockenhouse CF; Kremsner PG; Mordmüller B
Malar J; 2015 Feb; 14():72. PubMed ID: 25885325
[TBL] [Abstract][Full Text] [Related]
18. Plasmodium falciparum merozoite surface antigen-specific cytophilic IgG and control of malaria infection in a Beninese birth cohort.
Adamou R; Dechavanne C; Sadissou I; d'Almeida T; Bouraima A; Sonon P; Amoussa R; Cottrell G; Le Port A; Theisen M; Remarque EJ; Longacre S; Moutairou K; Massougbodji A; Luty AJF; Nuel G; Migot-Nabias F; Sanni A; Garcia A; Milet J; Courtin D
Malar J; 2019 Jun; 18(1):194. PubMed ID: 31185998
[TBL] [Abstract][Full Text] [Related]
19. Four year immunogenicity of the RTS,S/AS02(A) malaria vaccine in Mozambican children during a phase IIb trial.
Aide P; Dobaño C; Sacarlal J; Aponte JJ; Mandomando I; Guinovart C; Bassat Q; Renom M; Puyol L; Macete E; Herreros E; Leach A; Dubois MC; Demoitie MA; Lievens M; Vekemans J; Loucq C; Ballou WR; Cohen J; Alonso PL
Vaccine; 2011 Aug; 29(35):6059-67. PubMed ID: 21443960
[TBL] [Abstract][Full Text] [Related]
20. Functional Antibodies and Protection against Blood-stage Malaria.
Teo A; Feng G; Brown GV; Beeson JG; Rogerson SJ
Trends Parasitol; 2016 Nov; 32(11):887-898. PubMed ID: 27546781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
